Rockwell Net Interest Income from 2010 to 2026
| RMTI Stock | USD 1.06 0.06 6.00% |
Net Interest Income | First Reported 2019-03-31 | Previous Quarter -207 K | Current Value -230 K | Quarterly Volatility 278.8 K |
Check Rockwell Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Rockwell Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.6 M, Interest Expense of 1.4 M or Total Revenue of 122.5 M, as well as many indicators such as Price To Sales Ratio of 0.68, Dividend Yield of 0.0 or PTB Ratio of 1.66. Rockwell financial statements analysis is a perfect complement when working with Rockwell Medical Valuation or Volatility modules.
Rockwell | Net Interest Income | Build AI portfolio with Rockwell Stock |
The Net Interest Income trend for Rockwell Medical offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Rockwell Medical is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Rockwell Medical's Net Interest Income Growth Pattern
Below is the plot of the Net Interest Income of Rockwell Medical over the last few years. It is the difference between the revenue generated from a bank's interest-bearing assets and the expenses associated with paying its interest-bearing liabilities. Rockwell Medical's Net Interest Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Rockwell Medical's overall financial position and show how it may be relating to other accounts over time.
| Net Interest Income | 10 Years Trend |
|
Net Interest Income |
| Timeline |
Rockwell Net Interest Income Regression Statistics
| Arithmetic Mean | (237,189) | |
| Coefficient Of Variation | (488.82) | |
| Mean Deviation | 1,052,655 | |
| Median | 367,077 | |
| Standard Deviation | 1,159,422 | |
| Sample Variance | 1.3T | |
| Range | 3.1M | |
| R-Value | (0.81) | |
| Mean Square Error | 488.1B | |
| R-Squared | 0.66 | |
| Significance | 0.000075 | |
| Slope | (186,473) | |
| Total Sum of Squares | 21.5T |
Rockwell Net Interest Income History
About Rockwell Medical Financial Statements
Investors use fundamental indicators, such as Rockwell Medical's Net Interest Income, to determine how well the company is positioned to perform in the future. Although Rockwell Medical's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
| Last Reported | Projected for Next Year | ||
| Net Interest Income | -1 M | -1.1 M |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out the analysis of Rockwell Medical Correlation against competitors. For more detail on how to invest in Rockwell Stock please use our How to Invest in Rockwell Medical guide.You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is there potential for Health Care Equipment & Supplies market expansion? Will Rockwell introduce new products? Factors like these will boost the valuation of Rockwell Medical. Anticipated expansion of Rockwell directly elevates investor willingness to pay premium valuations. Understanding fair value requires weighing current performance against future potential. All the valuation information about Rockwell Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.18) | Revenue Per Share | Quarterly Revenue Growth (0.44) | Return On Assets | Return On Equity |
The market value of Rockwell Medical is measured differently than its book value, which is the value of Rockwell that is recorded on the company's balance sheet. Investors also form their own opinion of Rockwell Medical's value that differs from its market value or its book value, called intrinsic value, which is Rockwell Medical's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Rockwell Medical's market value can be influenced by many factors that don't directly affect Rockwell Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Rockwell Medical's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Rockwell Medical should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Rockwell Medical's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.